BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2026.
World J Clin Cases. Jan 26, 2026; 14(3): 117257
Published online Jan 26, 2026. doi: 10.12998/wjcc.v14.i3.117257
Table 1 Epidemiology and clinical characteristics of spaceflight-associated neuro-ocular syndrome
Ref.
Mission duration
Sample size
SANS prevalence
Key ocular findings
Imaging used
Mader et al[16]Long-duration ISSn = 7Approximately 60%ODE, globe flattening, choroidal foldsFundus, MRI
Martin Paez et al[13]Mixed missionsReview30%-70%ODE, hyperopiaMultimodal
Macias et al[2]Long-duration ISSn = 8Approximately 62%ONH edema, refractive shiftOCT, MRI
Ferguson et al[22]6-month ISS missionn = 11Approximately 55%Optic disc edemaOCT
Table 2 Imaging modalities and structural ocular changes in spaceflight-associated neuro-ocular syndrome
Imaging modality
Structural changes
Ref.
Clinical significance
OCTRNFL thickening, ODEMacias et al[2]; Mader et al[16]Early detection
MRIPosterior globe flatteningKramer et al[18]Confirms ICP effects
Fundus photographyChoroidal foldsMader et al[16]Structural deformation
UltrasoundON sheath diameter increaseFall et al[23]Surrogate ICP marker